CELU
Price:
$0.7129
Market Cap:
$17.15M
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing t...[Read more]
Industry
Biotechnology
IPO Date
2019-08-08
Stock Exchange
NASDAQ
Ticker
CELU
According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 51.87M. This represents a change of -49.50% compared to the average of 102.72M of the last 4 quarters.
The mean historical Enterprise Value of Celularity Inc. over the last ten years is 241.53M. The current 51.87M Enterprise Value has changed 2.05% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the March 2022 quarter at 1.12B. The Enterprise Value was at its lowest in in the December 2025 quarter at 63.14M.
Average
241.53M
Median
205.52M
Minimum
63.14M
Maximum
645.47M
Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 260.75%
Maximum Annual Enterprise Value = 645.47M
Minimum Annual Increase = -64.04%
Minimum Annual Enterprise Value = 63.14M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 63.14M | -44.43% |
| 2024 | 113.63M | 4.07% |
| 2023 | 109.19M | -52.96% |
| 2022 | 232.10M | -64.04% |
| 2021 | 645.47M | 260.75% |
| 2020 | 178.93M | -24.65% |
| 2019 | 237.47M | -32.60% |
The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
95.32M
5-year avg
232.71M
10-year avg
241.53M
Celularity Inc.’s Enterprise Value is greater than BioAtla, Inc. (9.00M), greater than Reviva Pharmaceuticals Holdings, Inc. (-19627463.00), greater than Annovis Bio, Inc. (20.80M), greater than FibroGen, Inc. (11.12M), greater than Actinium Pharmaceuticals, Inc. (-8924256.00), less than BioXcel Therapeutics, Inc. (118.31M), greater than Kezar Life Sciences, Inc. (-11018667.00), greater than PolyPid Ltd. (40.34M), greater than Tempest Therapeutics, Inc. (11.64M), greater than Generation Bio Co. (40.14M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 9.00M | $4.87M | |
| -19627463.00 | $2.33M | |
| 20.80M | $35.02M | |
| 11.12M | $36.69M | |
| -8924256.00 | $31.69M | |
| 118.31M | $35.20M | |
| -11018667.00 | $53.86M | |
| 40.34M | $47.08M | |
| 11.64M | $5.60M | |
| 40.14M | $35.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Celularity Inc.'s Enterprise Value?
What is the highest Enterprise Value for Celularity Inc. (CELU)?
What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?
What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?
How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?